Annual Operating Profit
-$388.28 M
-$180.95 M-87.27%
December 31, 2023
Summary
- As of February 23, 2025, PCVX annual operating income is -$388.28 million, with the most recent change of -$180.95 million (-87.27%) on December 31, 2023.
- During the last 3 years, PCVX annual operating profit has fallen by -$301.17 million (-345.77%).
- PCVX annual operating profit is now -992.72% below its all-time high of -$35.53 million, reached on December 31, 2018.
Performance
PCVX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$139.63 M
+$12.96 M+8.49%
September 30, 2024
Summary
- As of February 23, 2025, PCVX quarterly operating income is -$139.63 million, with the most recent change of +$12.96 million (+8.49%) on September 30, 2024.
- Over the past year, PCVX quarterly operating profit has stayed the same.
- PCVX quarterly operating profit is now -1055.32% below its all-time high of -$12.09 million, reached on September 30, 2019.
Performance
PCVX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$528.24 M
-$28.25 M-5.65%
September 30, 2024
Summary
- As of February 23, 2025, PCVX TTM operating income is -$528.24 million, with the most recent change of -$28.25 million (-5.65%) on September 30, 2024.
- Over the past year, PCVX TTM operating profit has stayed the same.
- PCVX TTM operating profit is now -3688.26% below its all-time high of -$13.94 million, reached on March 31, 2019.
Performance
PCVX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
PCVX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -87.3% | 0.0% | 0.0% |
| 3 y3 years | -345.8% | 0.0% | 0.0% |
| 5 y5 years | -992.7% | 0.0% | 0.0% |
PCVX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -280.4% | at low | -382.5% | +8.5% | -417.4% | at low |
| 5 y | 5-year | -620.1% | at low | -791.9% | +8.5% | -879.7% | at low |
| alltime | all time | -992.7% | at low | -1055.3% | +8.5% | -3688.3% | at low |
Vaxcyte Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$139.63 M(-8.5%) | -$528.24 M(+5.6%) |
| Jun 2024 | - | -$152.59 M(+33.4%) | -$499.99 M(+15.7%) |
| Mar 2024 | - | -$114.35 M(-6.0%) | -$432.08 M(+11.3%) |
| Dec 2023 | -$388.28 M(+87.3%) | -$121.67 M(+9.2%) | -$388.28 M(+17.9%) |
| Sep 2023 | - | -$111.39 M(+31.5%) | -$329.26 M(+19.2%) |
| Jun 2023 | - | -$84.68 M(+20.1%) | -$276.29 M(+15.7%) |
| Mar 2023 | - | -$70.54 M(+12.6%) | -$238.81 M(+15.2%) |
| Dec 2022 | -$207.33 M(+103.1%) | -$62.65 M(+7.2%) | -$207.33 M(+19.4%) |
| Sep 2022 | - | -$58.42 M(+23.8%) | -$173.62 M(+22.4%) |
| Jun 2022 | - | -$47.20 M(+20.8%) | -$141.85 M(+20.2%) |
| Mar 2022 | - | -$39.06 M(+35.0%) | -$118.00 M(+15.6%) |
| Dec 2021 | -$102.08 M | -$28.94 M(+8.6%) | -$102.08 M(+10.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$26.65 M(+14.1%) | -$92.27 M(+7.1%) |
| Jun 2021 | - | -$23.35 M(+0.9%) | -$86.14 M(+3.8%) |
| Mar 2021 | - | -$23.14 M(+21.0%) | -$82.98 M(-4.7%) |
| Dec 2020 | -$87.10 M(+61.6%) | -$19.13 M(-6.8%) | -$87.10 M(+4.2%) |
| Sep 2020 | - | -$20.52 M(+1.6%) | -$83.63 M(+11.2%) |
| Jun 2020 | - | -$20.19 M(-26.0%) | -$75.20 M(+11.8%) |
| Mar 2020 | - | -$27.27 M(+74.2%) | -$67.24 M(+24.7%) |
| Dec 2019 | -$53.92 M(+51.7%) | -$15.66 M(+29.5%) | -$53.92 M(+40.9%) |
| Sep 2019 | - | -$12.09 M(-1.2%) | -$38.26 M(+46.2%) |
| Jun 2019 | - | -$12.23 M(-12.3%) | -$26.18 M(+87.7%) |
| Mar 2019 | - | -$13.94 M | -$13.94 M |
| Dec 2018 | -$35.53 M | - | - |
FAQ
- What is Vaxcyte annual operating income?
- What is the all time high annual operating profit for Vaxcyte?
- What is Vaxcyte annual operating profit year-on-year change?
- What is Vaxcyte quarterly operating income?
- What is the all time high quarterly operating profit for Vaxcyte?
- What is Vaxcyte quarterly operating profit year-on-year change?
- What is Vaxcyte TTM operating income?
- What is the all time high TTM operating profit for Vaxcyte?
- What is Vaxcyte TTM operating profit year-on-year change?
What is Vaxcyte annual operating income?
The current annual operating profit of PCVX is -$388.28 M
What is the all time high annual operating profit for Vaxcyte?
Vaxcyte all-time high annual operating income is -$35.53 M
What is Vaxcyte annual operating profit year-on-year change?
Over the past year, PCVX annual operating income has changed by -$180.95 M (-87.27%)
What is Vaxcyte quarterly operating income?
The current quarterly operating profit of PCVX is -$139.63 M
What is the all time high quarterly operating profit for Vaxcyte?
Vaxcyte all-time high quarterly operating income is -$12.09 M
What is Vaxcyte quarterly operating profit year-on-year change?
Over the past year, PCVX quarterly operating income has changed by $0.00 (0.00%)
What is Vaxcyte TTM operating income?
The current TTM operating profit of PCVX is -$528.24 M
What is the all time high TTM operating profit for Vaxcyte?
Vaxcyte all-time high TTM operating income is -$13.94 M
What is Vaxcyte TTM operating profit year-on-year change?
Over the past year, PCVX TTM operating income has changed by $0.00 (0.00%)